Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
1 day ago · CNBC
Global
& newspaper;
Read Full Article →
Sourced From
CNBC
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
Source: CNBC — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: CNBC — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.